Global Generic Pharmaceuticals Market Outlook, Opportunities And Strategies – Includes Generic Pharmaceuticals Market Size
Learn about the global generic pharmaceuticals market through The Business Research Company, which provides information on generic pharmaceuticals market size, generic pharmaceuticals market drivers and restraints, generic pharmaceuticals market players, the COVID-19 impact on the generic pharmaceuticals market, and more.
The generic pharmaceuticals market size is expected to grow from $185.98 billion in 2020 to $258.16 billion in 2025 at a rate of 6.8%. The global generic pharmaceuticals market size is then expected to grow at a CAGR of 7.4% from 2025 and reach $369.15 billion in 2030.
The rising incidence of chronic diseases is one of the major drivers of the generic pharmaceuticals market.
Request A Sample For The Global Generic Pharmaceuticals Market Report:
The generic pharmaceuticals market consists of the sales of generic pharmaceuticals and relates to services by entities (organizations, sole traders, or partnerships) that produce generic pharmaceuticals including biosimilars.
Global generic pharmaceuticals market segments include:
By Therapy: CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, others
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Type: Biosimilar, Simple Generic
By Drug Delivery: Oral, Injectables, Dermal/Topical, Inhaler
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the global generic pharmaceuticals market, accounting for 48.3% of the total in 2021.
Generic pharmaceutical companies are increasingly using biomarkers in the drug development process to reduce the time taken to bring the product into the market. Biomarkers are biological indicators that are objectively measured and evaluated for biological processes, pathogenic processes, or pharmacological responses to a therapeutic intervention. They are helpful to predict the drug efficacy faster than conventional clinical endpoints, the point at which an undesired or abnormal effect of the drug is observed indicating withdrawal from therapy. Companies in this market are investing in the development of biomarkers for use in various activities such as tracking drug activity, studying pharmacodynamics (relationship between the drug concentration at the site of action and the biochemical and physiological effect) of drugs, and studying diseases and treatment pathways. Companies such as Genentech and Janssen are increasingly investing in the use of biomarkers for understanding the efficacy of a potential respiratory drug.
Major Market Players: Teva Pharmaceutical Industries Ltd., Novartis AG, Sun Pharmaceutical Industries Ltd., Fresenius Kabi, Aurobindo Pharma Limited.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)
The Generic Pharmaceuticals Market Report 2022 is one of a series of new reports from The Business Research Company that provides generic pharmaceuticals market overviews, analyzes and forecasts market size, share, generic pharmaceuticals market players, generic pharmaceuticals market segments and geographies, leading competitor revenues, profiles and market shares.
TBRC’s generic pharmaceuticals market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Here Is A List Of Similar Reports From The Business Research Company:
Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: